Guangzhou-based Sudao Information Technology, operator of mobile B2B pharmaceutical trading app Yaoshibang, has completed RMB 420 mln in Series C funding across two rounds. Shunwei Capital Partners led Series C1 funding with participation from Series B leader Green Pine Capital and ECC Capital. DCM Ventures led Series C2 with participation from SIG. To date, Yaoshibang has raised over RMB 600 mln.
Yaoshibang currently has over 150,000 active pharmacies and a monthly GMV of RMB 500 mln. The platform is expected to reach total annual transaction volume of RMB 10 bln this year.
Editor's Note: For more information on this topic, please see B2B Pharmaceutical Trading App 'Yaoshibang' Wins RMB 110 Mln Series B, MD 2/07/17 issue.